GERN


MLV Maintains Buy On Geron Following Collaboration Agreement With Janssen

In a research report issued today, MLV analyst George Zavoico maintained a Buy rating on Geron (NASDAQ:GERN) with a price target of $4.25, …

MLV Maintains Buy On Geron As Full Clinical Hold On Imetelstat Lifted

In a research note issued today, MLV analyst George Zavoico maintained a Buy rating on Geron (NASDAQ:GERN) with a $4.25 price target, following the …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts